IMPACT OF SGLT2 INHIBITORS ON HEART FAILURE (Atena Editora)

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributor.authorRANGEL, MARCO ANTÔNIO NETTO ARMANDO-
Autor(es): dc.contributor.authorCOSTA, MATHEUS MARQUES DA-
Autor(es): dc.contributor.authorMORAES, POLLINI PEREIRA DE-
Autor(es): dc.contributor.authorAZZI, THAÍS BARONI-
Autor(es): dc.contributor.authorCONCEIÇÃO, ANA CAROLINA ALVES DA-
Autor(es): dc.contributor.authorMATTOS, ANA CAROLINA MORAES-
Autor(es): dc.contributor.authorMACIEL, THAYNARA ALVES DE SOUZA-
Autor(es): dc.contributor.authorMORAES, THAINÁ PEREIRA DE-
Autor(es): dc.contributor.authorJOIA, KÍVIA DA SILVA-
Autor(es): dc.contributor.authorLOPES, PATRICK DE ABREU CUNHA-
Autor(es): dc.contributor.authorNOSE, ANDRE LUIS YAMAMOTO-
Autor(es): dc.contributor.authorRANGEL, RODRIGO NETTO ARMANDO-
Data de aceite: dc.date.accessioned2022-05-09T18:58:38Z-
Data de disponibilização: dc.date.available2022-05-09T18:58:38Z-
Data de envio: dc.date.issued2022-04-21-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/701825-
Resumo: dc.description.abstractHeart failure (HF) affects up to more than 20% of patients with type 2 diabetes (DM2), even more in the elderly. Finally, the updated clinical evidence of the benefits of SGLT2i in HF was summarized. Thus, this review aimed to analyze the cardioprotective mechanisms of glucose transporter sodium 2 inhibitors (SGLT2i) in patients with HF, as well as their clinical impact on cardiovascular events. to intracellular sodium-reducing molecules. This provides its consequent cardioprotective effect, which justifies its significant reduction in CV events, especially in higher-risk populations.pt_BR
Idioma: dc.language.isoenpt_BR
Palavras-chave: dc.subjectPATHOPHYSIOLOGYpt_BR
Título: dc.titleIMPACT OF SGLT2 INHIBITORS ON HEART FAILURE (Atena Editora)pt_BR
Tipo de arquivo: dc.typelivro digitalpt_BR
Aparece nas coleções:Livros digitais

Arquivos associados:
IMPACTO.pdf108,46 kBAdobe PDF/bitstream/capes/701825/1/IMPACTO.pdfDownload